Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes
Diabetes increases the risk for developing anemia by 2-3 fold, compared to those without diabetes and similar renal function. We examined hemoglobin (Hb) and packed cell volume (PCV) changes over three years in UK Prospective Diabetes Study (UKPDS) patients with newly-diagnosed type 2 diabetes rando...
| Main Author: | |
|---|---|
| Format: | Conference item |
| Published: |
American Diabetes Association
2016
|
| _version_ | 1826292059175124992 |
|---|---|
| author | Coleman, R |
| author_facet | Coleman, R |
| author_sort | Coleman, R |
| collection | OXFORD |
| description | Diabetes increases the risk for developing anemia by 2-3 fold, compared to those without diabetes and similar renal function. We examined hemoglobin (Hb) and packed cell volume (PCV) changes over three years in UK Prospective Diabetes Study (UKPDS) patients with newly-diagnosed type 2 diabetes randomized to diet, sulfonylurea, metformin or insulin therapy. |
| first_indexed | 2024-03-07T03:08:51Z |
| format | Conference item |
| id | oxford-uuid:b37c3bb0-d09f-4373-8156-c8d9ebc8c0aa |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:08:51Z |
| publishDate | 2016 |
| publisher | American Diabetes Association |
| record_format | dspace |
| spelling | oxford-uuid:b37c3bb0-d09f-4373-8156-c8d9ebc8c0aa2022-03-27T04:19:25ZReductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 DiabetesConference itemhttp://purl.org/coar/resource_type/c_5794uuid:b37c3bb0-d09f-4373-8156-c8d9ebc8c0aaSymplectic Elements at OxfordAmerican Diabetes Association2016Coleman, RDiabetes increases the risk for developing anemia by 2-3 fold, compared to those without diabetes and similar renal function. We examined hemoglobin (Hb) and packed cell volume (PCV) changes over three years in UK Prospective Diabetes Study (UKPDS) patients with newly-diagnosed type 2 diabetes randomized to diet, sulfonylurea, metformin or insulin therapy. |
| spellingShingle | Coleman, R Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title | Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title_full | Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title_fullStr | Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title_full_unstemmed | Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title_short | Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes |
| title_sort | reductions in hemoglobin and packed cell volume over 3 years in ukpds patients with newly diagnoses type 2 diabetes |
| work_keys_str_mv | AT colemanr reductionsinhemoglobinandpackedcellvolumeover3yearsinukpdspatientswithnewlydiagnosestype2diabetes |